Suehiro Iwata - Publications

Affiliations: 
Graduate University for Advanced Studies, Hayama-machi, Kanagawa-ken, Japan 

77 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Trimova G, Yamagata K, Iwata S, Hirata S, Zhang T, Uemura F, Satoh M, Biln N, Nakayamada S, Maksymowych WP, Tanaka Y. Tumour necrosis factor alpha promotes secretion of 14-3-3η by inducing necroptosis in macrophages. Arthritis Research & Therapy. 22: 24. PMID 32051018 DOI: 10.1186/s13075-020-2110-9  0.52
2020 Miyagawa I, Nakano K, Nakayamada S, Iwata S, Hanami K, Fukuyo S, Kubo S, Kawabe A, Miyazaki Y, Inoue Y, Ueno M, Ohkubo N, Fujita Y, Tanaka Y. The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus. International Journal of Rheumatic Diseases. PMID 32020727 DOI: 10.1111/1756-185X.13792  0.52
2020 Zhang M, Iwata S, Hajime M, Ohkubo N, Todoroki Y, Miyata H, Ueno M, Hao H, Zhang T, Fan J, Nakayamada S, Yamagata K, Tanaka Y. Methionine commits cells to differentiate into plasmablasts through epigenetic regulation of BTB and CNC homolog 2 by the methyltransferase enhancer of zeste homolog 2. Arthritis & Rheumatology (Hoboken, N.J.). PMID 31961063 DOI: 10.1002/art.41208  0.52
2019 Miyagawa I, Nakano K, Iwata S, Nakayamada S, Saito K, Hanami K, Fukuyo S, Kubo S, Kawabe A, Miyazaki Y, Tanaka Y. Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet's disease. Arthritis Research & Therapy. 21: 151. PMID 31228955 DOI: 10.1186/s13075-019-1933-8  0.52
2019 Mori H, Okada Y, Kawaguchi M, Iwata S, Yoshikawa M, Sonoda S, Sugai K, Tanaka K, Hajime M, Narisawa M, Tanaka Y. A Study of the Vascular Endothelial Function in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis. Internal Medicine (Tokyo, Japan). 58: 1383-1390. PMID 31092771 DOI: 10.2169/internalmedicine.1564-18  0.52
2019 Tanaka Y, Kubo S, Miyagawa I, Iwata S, Nakayamada S. Lymphocyte phenotype and its application to precision medicine in systemic autoimmune diseases. Seminars in Arthritis and Rheumatism. PMID 31079846 DOI: 10.1016/j.semarthrit.2019.04.007  0.52
2018 Yoshikawa M, Nakayamada S, Kubo S, Nawata A, Kitanaga Y, Iwata S, Sakata K, Ma X, Wang SP, Nakano K, Saito K, Tanaka Y. Type I and II interferons commit to abnormal expression of chemokine receptor on B cells in patients with systemic lupus erythematosus. Clinical Immunology (Orlando, Fla.). 200: 1-9. PMID 30576845 DOI: 10.1016/j.clim.2018.12.017  0.52
2018 Ueno M, Nakano K, Yoshinari H, Nakayamada S, Iwata S, Kubo S, Miyagawa I, Tanaka Y. An Autopsy Case with Cerebral Hemorrhaging Due to Disseminated Aspergillosis During Glucocorticoid Therapy for Overlap Syndrome of Systemic Lupus Erythematosus and Systemic Sclerosis. Internal Medicine (Tokyo, Japan). PMID 30568120 DOI: 10.2169/internalmedicine.1226-18  0.52
2018 Ishikawa Y, Iwata S, Hanami K, Nawata A, Zhang M, Yamagata K, Hirata S, Sakata K, Todoroki Y, Nakano K, Nakayamada S, Satoh M, Tanaka Y. Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis. Arthritis Research & Therapy. 20: 240. PMID 30367666 DOI: 10.1186/s13075-018-1737-2  0.52
2018 Miyagawa I, Nakano K, Nakayamada S, Iwata S, Hanami K, Fukuyo S, Kubo S, Inoue Y, Ueno M, Tanaka Y. Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus. International Journal of Rheumatic Diseases. PMID 30338639 DOI: 10.1111/1756-185X.13387  0.52
2018 Torigoe M, Sakata K, Ishii A, Iwata S, Nakayamada S, Tanaka Y. Hydroxychloroquine efficiently suppresses inflammatory responses of human class-switched memory B cells via Toll-like receptor 9 inhibition. Clinical Immunology (Orlando, Fla.). PMID 29981383 DOI: 10.1016/j.clim.2018.07.003  0.52
2018 Miyagawa I, Nakayamada S, Nakano K, Kubo S, Iwata S, Miyazaki Y, Yoshikawa M, Yoshinari H, Tanaka Y. Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis. Rheumatology (Oxford, England). PMID 29618121 DOI: 10.1093/rheumatology/key069  0.52
2018 Miyata M, Kakeda S, Kudo K, Iwata S, Tanaka Y, Wang Y, Korogi Y. Evaluation of oxygen extraction fraction in systemic lupus erythematosus patients using quantitative susceptibility mapping. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X18764829. PMID 29547080 DOI: 10.1177/0271678X18764829  0.52
2018 Nagayasu A, Kubo S, Nakano K, Nakayamada S, Iwata S, Miyagawa I, Fukuyo S, Saito K, Tanaka Y. IgG4-related Pleuritis with Elevated Adenosine Deaminase in Pleural Effusion: A Case Report. Internal Medicine (Tokyo, Japan). PMID 29526951 DOI: 10.2169/internalmedicine.0387-17  0.52
2018 Ide S, Kakeda S, Miyata M, Iwata S, Ohkubo N, Nakayamada S, Futatsuya K, Watanabe K, Moriya J, Fujino Y, Tanaka Y, Korogi Y. Intracranial vessel wall lesions in patients with systematic lupus erythematosus. Journal of Magnetic Resonance Imaging : Jmri. PMID 29473985 DOI: 10.1002/jmri.25966  0.52
2018 Iwata S, Saito K, Hirata S, Ohkubo N, Nakayamada S, Nakano K, Hanami K, Kubo S, Miyagawa I, Yoshikawa M, Miyazaki Y, Yoshinari H, Tanaka Y. Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus. Lupus. 961203317749047. PMID 29308726 DOI: 10.1177/0961203317749047  0.52
2017 Miyata M, Kakeda S, Iwata S, Nakayamada S, Ide S, Watanabe K, Moriya J, Tanaka Y, Korogi Y. Enlarged perivascular spaces are associated with the disease activity in systemic lupus erythematosus. Scientific Reports. 7: 12566. PMID 28974720 DOI: 10.1038/s41598-017-12966-4  0.52
2017 Tanaka Y, Kubo S, Iwata S, Yoshikawa M, Nakayamada S. B cell phenotypes, signaling and their roles in secretion of antibodies in systemic lupus erythematosus. Clinical Immunology (Orlando, Fla.). PMID 28789968 DOI: 10.1016/j.clim.2017.07.010  0.52
2017 Torigoe M, Iwata S, Nakayamada S, Sakata K, Zhang M, Hajime M, Miyazaki Y, Narisawa M, Ishii K, Shibata H, Tanaka Y. Metabolic Reprogramming Commits Differentiation of Human CD27(+)IgD(+) B Cells to Plasmablasts or CD27(-)IgD(-) Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 28626065 DOI: 10.4049/jimmunol.1601908  0.52
2017 Kubo S, Nakayamada S, Yoshikawa M, Miyazaki Y, Sakata K, Nakano K, Hanami K, Iwata S, Miyagawa I, Saito K, Tanaka Y. Peripheral immunophenotyping identifies three subgroups based on T cell heterogeneity in lupus patients. Arthritis & Rheumatology (Hoboken, N.J.). PMID 28605137 DOI: 10.1002/art.40180  0.52
2017 Nakayamada S, Kubo S, Yoshikawa M, Miyazaki Y, Yunoue N, Iwata S, Miyagawa I, Hirata S, Nakano K, Saito K, Tanaka Y. Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis. Rheumatology (Oxford, England). PMID 28371836 DOI: 10.1093/rheumatology/kex012  0.52
2016 Nakayamada S, Kubo S, Iwata S, Tanaka Y. Erratum to: Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. PMID 27699710 DOI: 10.1007/s40259-016-0198-x  0.52
2016 Nakayamada S, Kubo S, Iwata S, Tanaka Y. Chemical JAK inhibitors for the treatment of rheumatoid arthritis. Expert Opinion On Pharmacotherapy. PMID 27690665 DOI: 10.1080/14656566.2016.1241237  0.52
2016 Nakayamada S, Kubo S, Iwata S, Tanaka Y. Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. PMID 27577235 DOI: 10.1007/s40259-016-0190-5  0.52
2016 Iwata S, Tanaka Y. Progress in understanding the safety and efficacy of Janus kinase inhibitors for treatment of rheumatoid arthritis. Expert Review of Clinical Immunology. 1-11. PMID 27253519 DOI: 10.1080/1744666X.2016.1189826  0.52
2016 Iwata S, Tanaka Y. B-cell subsets, signaling and their roles in secretion of autoantibodies. Lupus. 25: 850-6. PMID 27252261 DOI: 10.1177/0961203316643172  0.52
2015 Iwata S, Tanaka Y. The importance of B cell-T cell interaction in autoimmune diseases. Nihon Rinshō Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology. 38: 398-402. PMID 26725861 DOI: 10.2177/jsci.38.398  0.52
2015 Takahashi S, Ishii M, Namkoong H, Hegab AE, Asami T, Yagi K, Sasaki M, Haraguchi M, Sato M, Kameyama N, Asakura T, Suzuki S, Tasaka S, Iwata S, Hasegawa N, et al. Pneumococcal Infection Aggravates Elastase-Induced Emphysema via MMP-12 Overexpression. The Journal of Infectious Diseases. PMID 26563237 DOI: 10.1093/infdis/jiv527  0.4
2015 Hirahara K, Onodera A, Villarino AV, Bonelli M, Sciumè G, Laurence A, Sun HW, Brooks SR, Vahedi G, Shih HY, Gutierrez-Cruz G, Iwata S, Suzuki R, Mikami Y, Okamoto Y, et al. Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine Specificity. Immunity. 42: 877-89. PMID 25992861 DOI: 10.1016/J.Immuni.2015.04.014  0.32
2015 Tono K, Nango E, Sugahara M, Song C, Park J, Tanaka T, Tanaka R, Joti Y, Kameshima T, Ono S, Hatsui T, Mizohata E, Suzuki M, Shimamura T, Tanaka Y, ... Iwata S, et al. Diverse application platform for hard X-ray diffraction in SACLA (DAPHNIS): application to serial protein crystallography using an X-ray free-electron laser. Journal of Synchrotron Radiation. 22: 532-7. PMID 25931065 DOI: 10.1107/S1600577515004464  0.52
2015 Yoshikawa M, Nakayamada S, Iwata S, Kubo S, Yunoue N, Wang SP, Tanaka Y. [Abnormal expression of chemokine receptor on B cells in patients with SLE]. Nihon Rinshō Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology. 38: 65-8. PMID 25765690 DOI: 10.2177/jsci.38.65  0.52
2015 Wang SP, Iwata S, Nakayamada S, Niiro H, Jabbarzadeh-Tabrizi S, Kondo M, Kubo S, Yoshikawa M, Tanaka Y. Amplification of IL-21 signalling pathway through Bruton's tyrosine kinase in human B cell activation. Rheumatology (Oxford, England). 54: 1488-97. PMID 25724205 DOI: 10.1093/rheumatology/keu532  0.52
2015 Nakayamada S, Iwata S, Tanaka Y. Relevance of lymphocyte subsets to B cell-targeted therapy in systemic lupus erythematosus. International Journal of Rheumatic Diseases. 18: 208-18. PMID 25557245 DOI: 10.1111/1756-185X.12534  0.32
2015 Namkoong H, Funatsu Y, Oishi K, Akeda Y, Hiraoka R, Takeshita K, Asami T, Yagi K, Kimizuka Y, Ishii M, Tasaka S, Suzuki Y, Iwata S, Betsuyaku T, Hasegawa N. Comparison of the immunogenicity and safety of polysaccharide and protein-conjugated pneumococcal vaccines among the elderly aged 80 years or older in Japan: an open-labeled randomized study. Vaccine. 33: 327-32. PMID 25448102 DOI: 10.1016/j.vaccine.2014.11.023  0.4
2015 Iwata S, Yamaoka K, Niiro H, Jabbarzadeh-Tabrizi S, Wang SP, Kondo M, Yoshikawa M, Akashi K, Tanaka Y. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus. Lupus. 24: 695-704. PMID 25432781 DOI: 10.1177/0961203314560424  0.32
2015 Sugahara M, Mizohata E, Nango E, Suzuki M, Tanaka T, Masuda T, Tanaka R, Shimamura T, Tanaka Y, Suno C, Ihara K, Pan D, Kakinouchi K, Sugiyama S, Murata M, ... ... Iwata S, et al. Grease matrix as a versatile carrier of proteins for serial crystallography. Nature Methods. 12: 61-3. PMID 25384243 DOI: 10.1038/Nmeth.3172  0.52
2015 Iwata S, Nakayamada S, Fukuyo S, Kubo S, Yunoue N, Wang SP, Yoshikawa M, Saito K, Tanaka Y. Activation of Syk in peripheral blood B cells in patients with rheumatoid arthritis: a potential target for abatacept therapy. Arthritis & Rheumatology (Hoboken, N.J.). 67: 63-73. PMID 25303149 DOI: 10.1002/art.38895  0.32
2015 Iwata S, Tanaka Y. The importance of B cell-T cell interaction in autoimmune diseases Japanese Journal of Clinical Immunology. 38: 398-402.  0.32
2015 Yoshkawa M, Nakayamada S, Iwata S, Kubo S, Yunoue N, Wang SP, Tanaka Y. Abnormal expression of chemokine receptor on b cells in patients with SLE Japanese Journal of Clinical Immunology. 38: 65-68.  0.52
2014 Wang SP, Iwata S, Nakayamada S, Sakata K, Yamaoka K, Tanaka Y. Tofacitinib, a JAK inhibitor, inhibits human B cell activation in vitro. Annals of the Rheumatic Diseases. 73: 2213-5. PMID 25157177 DOI: 10.1136/annrheumdis-2014-205615  0.32
2014 Iwata S. Analysis of hydrogen bond energies and hydrogen bonded networks in water clusters (H2O)20 and (H2O)25 using the charge-transfer and dispersion terms. Physical Chemistry Chemical Physics : Pccp. 16: 11310-7. PMID 24800849 DOI: 10.1039/C4Cp01204F  0.4
2014 Nakayamada S, Poholek AC, Lu KT, Takahashi H, Kato M, Iwata S, Hirahara K, Cannons JL, Schwartzberg PL, Vahedi G, Sun HW, Kanno Y, O'Shea JJ. Type I IFN induces binding of STAT1 to Bcl6: divergent roles of STAT family transcription factors in the T follicular helper cell genetic program. Journal of Immunology (Baltimore, Md. : 1950). 192: 2156-66. PMID 24489092 DOI: 10.4049/Jimmunol.1300675  0.32
2014 Kubo S, Saito K, Hirata S, Fukuyo S, Yamaoka K, Sawamukai N, Nawata M, Iwata S, Mizuno Y, Tanaka Y. Abatacept inhibits radiographic progression in patients with rheumatoid arthritis: a retrospective analysis of 6 months of abatacept treatment in routine clinical practice. The ALTAIR study. Modern Rheumatology / the Japan Rheumatism Association. 24: 42-51. PMID 24261758 DOI: 10.3109/14397595.2013.854051  0.32
2014 Fukuyo S, Saito K, Yamaoka K, Sawamukai N, Hirata S, Nawata M, Iwata S, Tanaka Y. Efficacy and safety of reducing duration of infliximab infusion. Modern Rheumatology / the Japan Rheumatism Association. 24: 275-80. PMID 24251990 DOI: 10.3109/14397595.2013.843747  0.32
2014 Kubo S, Yamaoka K, Kondo M, Yamagata K, Zhao J, Iwata S, Tanaka Y. The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells. Annals of the Rheumatic Diseases. 73: 2192-8. PMID 24013646 DOI: 10.1136/annrheumdis-2013-203756  0.52
2014 Kawasaki Y, Ishibashi C, Iwata S, Matsuzawa H. Quantum chemical studies of M(BH4)n and M(AlH4)n, M=Li and Na Computational and Theoretical Chemistry. 1043: 79-89. DOI: 10.1016/J.Comptc.2014.05.016  0.4
2013 Hirata S, Saito K, Kubo S, Fukuyo S, Mizuno Y, Iwata S, Nawata M, Sawamukai N, Nakano K, Yamaoka K, Tanaka Y. Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study. Arthritis Research & Therapy. 15: R135. PMID 24286472 DOI: 10.1186/ar4315  0.32
2013 Iwata S, Bandyopadhyay P, Xantheas SS. Cooperative roles of charge transfer and dispersion terms in hydrogen-bonded networks of (H2O)n, n = 6, 11, and 16. The Journal of Physical Chemistry. A. 117: 6641-51. PMID 23805893 DOI: 10.1021/Jp403837Z  0.4
2013 Iwata S, Saito K, Tokunaga M, Tanaka Y. Persistent memory B cell down-regulation after 6-year remission induced by rituximab therapy in patients with systemic lupus erythematosus Lupus. 22: 538-540. PMID 23423251 DOI: 10.1177/0961203313477899  0.32
2013 Kubo S, Saito K, Hirata S, Fukuyo S, Yamaoka K, Sawamukai N, Nawata M, Iwata S, Mizuno Y, Tanaka Y. Abatacept inhibits radiographic progression in patients with rheumatoid arthritis: a retrospective analysis of 6 months of abatacept treatment in routine clinical practice. The ALTAIR study Modern Rheumatology. 1-10. DOI: 10.1007/s10165-013-0853-8  0.32
2012 Iwata S, Saito K, Hirata S, Tanaka Y. Phenotypic changes of lymphocyte in a patient with IgG4-related disease after corticosteroid therapy. Annals of the Rheumatic Diseases. 71: 2058-9. PMID 22791745 DOI: 10.1136/annrheumdis-2012-201657  0.32
2012 Iwata S, Saito K, Tokunaga M, Tanaka Y. B cell or T cell-dominant recurrence after rituximab therapy in patients with SLE Annals of the Rheumatic Diseases. 71: 1749-1750. PMID 22586167 DOI: 10.1136/annrheumdis-2012-201317  0.32
2012 Iwata S. Energy analysis of weak electron-donor-acceptor complexes and water clusters with the perturbation theory based on the locally projected molecular orbitals: charge-transfer and dispersion terms. Physical Chemistry Chemical Physics : Pccp. 14: 7787-94. PMID 22547259 DOI: 10.1039/C2Cp40217C  0.4
2012 Iwata S, Yamaoka K, Niiro H, Nakano K, Wang SP, Akashi K, Tanaka Y. Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation Journal of Allergy and Clinical Immunology. 129: 1594-1601. PMID 22541243 DOI: 10.1016/j.jaci.2012.03.014  0.32
2012 Iwata S, Yamaoka K, Niiro H, Nakano K, Wang SP, Saito K, Akashi K, Tanaka Y. [Involvement of Syk in pathology of systemic autoimmune disease]. Nihon Rinshō Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology. 35: 56-61. PMID 22374444 DOI: 10.2177/jsci.35.56  0.52
2012 Maeshima K, Yamaoka K, Kubo S, Nakano K, Iwata S, Saito K, Ohishi M, Miyahara H, Tanaka S, Ishii K, Yoshimatsu H, Tanaka Y. The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells Arthritis and Rheumatism. 64: 1790-1798. PMID 22147632 DOI: 10.1002/art.34329  0.32
2012 Tanaka Y, Yamanaka H, Saito K, Iwata S, Miyagawa I, Seto Y, Momohara S, Nagasawa H, Kameda H, Kaneko Y, Izumi K, Amano K, Takeuchi T. Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept. Modern Rheumatology / the Japan Rheumatism Association. 22: 186-94. PMID 21901357 DOI: 10.1007/s10165-011-0510-z  0.32
2011 Iwata S. Dispersion energy evaluated by using locally projected occupied and excited molecular orbitals for molecular interaction. The Journal of Chemical Physics. 135: 094101. PMID 21913747 DOI: 10.1063/1.3629777  0.4
2011 Kubo S, Iwata S, Saito K, Tanaka Y. Successful treatment of primary biliary cirrhosis with etanercept in a patient with rheumatoid arthritis Joint, Bone, Spine : Revue Du Rhumatisme. 78: 535-536. PMID 21703904 DOI: 10.1016/j.jbspin.2011.01.011  0.32
2011 Iwata S, Saito K, Tokunaga M, Yamaoka K, Nawata M, Yukawa S, Hanami K, Fukuyo S, Miyagawa I, Kubo S, Tanaka Y. Phenotypic changes of lymphocytes in patients with systemic lupus erythematosus who are in longterm remission after B cell depletion therapy with rituximab Journal of Rheumatology. 38: 633-641. PMID 21159836 DOI: 10.3899/jrheum.100729  0.32
2011 Iwata S, Saito K, Yamaoka K, Tsujimura S, Nawata M, Hanami K, Tanaka Y. Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease Modern Rheumatology. 21: 184-191. PMID 21052764 DOI: 10.1007/s10165-010-0370-y  0.32
2011 Kubo S, Iwata S, Saito K, Tanaka Y. Effectiveness of etanercept in primary biliary cirrhosis associated with rheumatoid arthritis | Efficacité de l'étanercept dans une cirrhose biliaire primitive associée à une polyarthrite rhumatoïde Revue Du Rhumatisme (Edition Francaise). 78: 589-590. DOI: 10.1016/j.rhum.2011.04.012  0.32
2010 Iwata S. Absolutely local occupied and excited molecular orbitals in the third-order single excitation perturbation theory for molecular interaction. The Journal of Physical Chemistry. A. 114: 8697-704. PMID 20429565 DOI: 10.1021/Jp101483T  0.4
2010 Kurihara R, Yamaoka K, Sawamukai N, Shimajiri S, Oshita K, Yukawa S, Tokunaga M, Iwata S, Saito K, Chiba K, Tanaka Y. C5a promotes migration, proliferation, and vessel formation in endothelial cells Inflammation Research. 59: 659-666. PMID 20217457 DOI: 10.1007/s00011-010-0178-4  0.32
2010 Suzuki K, Saito K, Tsujimura S, Nakayamada S, Yamaoka K, Sawamukai N, Iwata S, Nawata M, Nakano K, Tanaka Y. Tacrolimus, a calcineurin inhibitor, overcomes treatment unresponsiveness mediated by P-glycoprotein on lymphocytes in refractory rheumatoid arthritis Journal of Rheumatology. 37: 512-520. PMID 20080907 DOI: 10.3899/jrheum.090048  0.32
2009 Iwata S, Saito K, Yamaoka K, Tsujimura S, Nawata M, Suzuki K, Tanaka Y. Effects of anti-TNF-α antibody infliximab in refractory entero-Behçet's disease Rheumatology. 48: 1012-1013. PMID 19465589 DOI: 10.1093/rheumatology/kep126  0.32
2008 Iwata S. Absolutely local excited orbitals in the higher order perturbation expansion for the molecular interaction. The Journal of Physical Chemistry. B. 112: 16104-9. PMID 19367996 DOI: 10.1021/Jp805883C  0.4
2008 Takeuchi T, Yamanaka H, Inoue E, Nagasawa H, Nawata M, Ikari K, Saito K, Sekiguchi N, Sato E, Kameda H, Iwata S, Mochizuki T, Amano K, Tanaka Y. Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J). Modern Rheumatology / the Japan Rheumatism Association. 18: 447-54. PMID 18493716 DOI: 10.1007/s10165-008-0077-5  0.32
2008 Tanaka Y, Takeuchi T, Inoue E, Saito K, Sekiguchi N, Sato E, Nawata M, Kameda H, Iwata S, Amano K, Yamanaka H. Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2). Modern Rheumatology / the Japan Rheumatism Association. 18: 146-52. PMID 18283523 DOI: 10.1007/s10165-008-0026-3  0.32
2007 Iwata S. Theoretical studies of group 1 metal complexes with hydrogen fluoride, M(HF)n, M = Li, Na, and K: a new type of electrides. The Journal of Physical Chemistry. A. 111: 7499-503. PMID 17579374 DOI: 10.1021/Jp071422Z  0.4
2007 Yamaoka K, Saito K, Hanami K, Nakayamada S, Nawata M, Iwata S, Azuma T, Tanaka Y. A case of life-threatening refractory polychondritis successfully treated with combined intensive immunosuppressive therapy with methotrexate Modern Rheumatology. 17: 144-147. PMID 17437170 DOI: 10.1007/s10165-006-0548-5  0.32
2007 Tokunaga M, Saito K, Kawabata D, Imura Y, Fujii T, Nakayamada S, Tsujimura S, Nawata M, Iwata S, Azuma T, Mimori T, Tanaka Y. Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system Annals of the Rheumatic Diseases. 66: 470-475. PMID 17107983 DOI: 10.1136/ard.2006.057885  0.32
2006 Rodriguez-Garcia V, Yagi K, Hirao K, Iwata S, Hirata S. Franck-Condon factors based on anharmonic vibrational wave functions of polyatomic molecules. The Journal of Chemical Physics. 125: 014109. PMID 16863289 DOI: 10.1063/1.2209676  0.4
2006 Fujii Y, Fujii K, Iwata S, Suzuki K, Azuma T, Saito K, Tanaka Y. Abnormal intracellular distribution of NFAT1 in T lymphocytes from patients with systemic lupus erythematosus and characteristic clinical features Clinical Immunology. 119: 297-306. PMID 16503201 DOI: 10.1016/j.clim.2006.01.001  0.32
2005 Saito K, Nawata M, Iwata S, Tokunaga M, Tanaka Y. Extremely high titer of anti-human chimeric antibody following re-treatment with rituximab in a patient with active systemic lupus erythematosus [7] Rheumatology. 44: 1462-1464. PMID 16105908 DOI: 10.1093/rheumatology/kei075  0.32
2003 Takahashi O, Joyabu M, Mitani M, Saito K, Iwata S. Theoretical studies on the molecular dependence of bond dissociation after core excitations II: CH(3)CO(CH(20)(n)CN, n = 0-3. Journal of Computational Chemistry. 24: 1329-35. PMID 12827674 DOI: 10.1002/Jcc.10284  0.32
1995 Seki K, Kobiki K, Komiyama S, Nishio M, Hirata S, Ozawa N, Iwata S, Lin BL, Miyamoto N, Iwata Y. [Total laparoscopic hysterectomy with abdominal wall-lift method]. Nihon Sanka Fujinka Gakkai Zasshi. 47: 1397-400. PMID 8568364  0.4
Show low-probability matches.